The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Non-Hodgkin’s Lymphomas
Open accessAbstract
OverviewNon-Hodgkin's lymphomas (NHLs) are a heterogeneous group of lymphoproliferative disorders originating in B-, T-, or natural killer (NK) lymphocytes.In the United States, B-cell lymphomas represent 80% to 85% of all cases, with 15% to 20% being T-cell lymphomas; NK lymphomas are very rare.In 2009, an estimated 65,980 new cases of NHL will be diagnosed and 19,500 will die of the disease. 1 NHL is the sixth leading site of new cancer cases among men and fifth among women, accounting for 4% to 5% of new cancer cases and 3% to 4% of cancer-related deaths.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Self-citationCoiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationJemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationWHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Self-citationHarris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Self-citationClinical staging of chronic lymphocytic leukemia
Rai, K., Sawitsky, A., Cronkite, E., Chanana, A., Levy, R., & Pasternack, B. (1975) · Blood · doi:10.1182/blood.v46.2.219.219 · Cited by 2,784
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., et al. (1999) · Blood · doi:10.1182/blood.v94.6.1840 · Cited by 2,642
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
Pfreundschuh, M., Trümper, L., Österborg, A., Pettengell, R., Trneny, M., Imrie, K., Ma, D., Gill, D., Walewski, J., Zinzani, P.-L., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70664-7 · Cited by 2,076
Cheson, B., Bennett, J., Grever, M., Kay, N., Keating, M., O'Brien, S., & Rai, K. (1996) · Blood · doi:10.1182/blood.v87.12.4990.bloodjournal87124990 · Cited by 1,819
Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v · Cited by 1,778
Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., Rosenberg, S. A., Coltman, C. A., & Tubiana, M. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1630 · Cited by 1,639
Shimoyama, M., & members of The Lymphoma Study Group (1984–87) (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08051.x · Cited by 1,608
Feugier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R., Fermé, C., Christian, B., Lepage, E., Tilly, H., Morschhauser, F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.131 · Cited by 1,486
Habermann, T. M., Weller, E. A., Morrison, V. A., Gascoyne, R. D., Cassileth, P. A., Cohn, J. B., Dakhil, S. R., Woda, B., Fisher, R. I., Peterson, B. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1003 · Cited by 1,355
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Hiddemann, W. (2005) · Blood · doi:10.1182/blood-2005-01-0016 · Cited by 1,320
Armitage, J. O., & Weisenburger, D. D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2780 · Cited by 1,251
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702053160603 · Cited by 1,199
Witzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,170
Self-citationDuvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70002-0 · Cited by 1,130
Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marcé, S., López-Guillermo, A., Campo, E., & Montserrat, E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023143 · Cited by 1,055
Olsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., Parker, S., Frankel, S. R., Chen, C., Ricker, J. L., Arduino, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2434 · Cited by 1,055
Self-citationMiller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E., & Fisher, R. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390104 · Cited by 1,004
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G. A., Larson, R. A., Cheson, B. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432402 · Cited by 1,001
Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K., Klasa, R., MacPherson, N., O'Reilly, S., Spinelli, J. J., Sutherland, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.137 · Cited by 987
Thiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70989-4 · Cited by 974
Marcus, R. (2005) · Blood · doi:10.1182/blood-2004-08-3175 · Cited by 967
Keating, M. J., O’Brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.051 · Cited by 950
Self-citationKeating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
Self-citationRosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 914
Self-citationCoiffier, B., Haïoun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D. D. F., Johnson, P., Lister, A., Feuring‐Buske, M., Radford, J. A., et al. (1998) · PubMed · doi:10.1182/blood.v92.6.1927 · Cited by 893
Czuczman, M. S., Grillo-López, A. J., White, C. A., Saleh, M., Gordon, L., LoBuglio, A. F., Jonas, C., Klippenstein, D., Dallaire, B., & Varns, C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.268 · Cited by 856
Self-citationHarris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Annals of Oncology · doi:10.1023/a:1008375931236 · Cited by 846
Self-citation131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Kaminski, M. S., Tuck, M., Estes, J., Kolstad, A., Ross, C. W., Zasadny, K., Regan, D., Kison, P., Fisher, S., Kroll, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041511 · Cited by 716
Self-citationDuvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706
Fisher, R. I., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9665 · Cited by 704
Witzig, T. E., Flinn, I. W., Gordon, L. I., Emmanouilides, C., Czuczman, M. S., Saleh, M. N., Cripe, L., Wiseman, G., Olejnik, T., Multani, P. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.017 · Cited by 651
Self-citationOlsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Self-citationGallamini, A. (2004) · Blood · doi:10.1182/blood-2003-09-3080 · Cited by 598
van Oers, M. H. J., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., Gascoyne, R. D., Jack, A., van't Veer, M., Vranovsky, A., Holte, H., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021113 · Cited by 592
Kaminski, M. S., Zelenetz, A. D., Press, O. W., Saleh, M., Leonard, J., Fehrenbacher, L., Lister, T. A., Stagg, R. J., Tidmarsh, G. F., Kroll, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.19.3918 · Cited by 584
Self-citationForstpointner, R. (2004) · Blood · doi:10.1182/blood-2004-04-1323 · Cited by 580
Lenz, G., Dreyling, M., Hoster, E., Wörmann, B., Dührsen, U., Metzner, B., Eimermacher, H., Neubauer, A., Wandt, H., Steinhauer, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.133 · Cited by 574
Byrd, J. C. (2003) · Blood · doi:10.1182/blood-2002-04-1258 · Cited by 571
Self-citationThomas, D. A., Faderl, S., O'Brien, S., Bueso‐Ramos, C., Cortes, J., Garcia‐Manero, G., Giles, F. J., Verstovsek, S., Wierda, W. G., Pierce, S. A., et al. (2006) · Cancer · doi:10.1002/cncr.21776 · Cited by 566
Self-citationAlemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia
Hillmen, P., Skotnicki, A. B., Robak, T., Jaksic, B., Dmoszynska, A., Wu, J., Sirard, C., & Mayer, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9098 · Cited by 561
ALK+ lymphoma: clinico-pathological findings and outcome.
Falini, B., Pileri, S. A., Zinzani, P. L., Carbone, A., Zagonel, V., Wolf‐Peeters, C. D., Verhoef, G. E. G., Menestrina, F., Todeschini, G., Paulli, M., et al. (1999) · PubMed · doi:10.1182/blood.v93.8.2697 · Cited by 560
Tsukasaki, K., Hermine, O., Bazarbachi, A., Ratner, L., Ramos, J. C., Harrington, W., O’Mahony, D., Janik, J. E., Bittencourt, A. L., Taylor, G. P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2428 · Cited by 558
Romaguera, J. E., Fayad, L., Rodriguez, M. A., Broglio, K. R., Hagemeister, F. B., Pro, B., McLaughlin, P., Younes, A., Samaniego, F., Goy, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1825 · Cited by 557
Self-citationDefining early mycosis fungoides
Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., Burg, G., Cerroni, L., Dreno, B., Glusac, E., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.057 · Cited by 550
Groves, F. D., Linet, M. S., Travis, L. B., & Devesa, S. S. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1240 · Cited by 526
Gascoyne, R. D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B. F., Greiner, T. C., Morris, S. W., Connors, J. M., Vose, J. M., Viswanatha, D. S., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3913 · Cited by 524
Self-citationWierda, W., O’Brien, S., Wen, S., Faderl, S., Garcia-Manero, G., Thomas, D., Do, K.-A., Cortes, J., Koller, C., Beran, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.516 · Cited by 524
Self-citationDuvic, M. A., Martín, Á. G., Kim, Y. H., Olsen, E. A., Wood, G. S., Crowley, C., & Yocum, R. C. (2001) · PubMed · Cited by 489
Self-citationForstpointner, R., Unterhalt, M., Dreyling, M., Bock, H.-P., Repp, R., Wandt, H., Pott, C., Seymour, J. F., Metzner, B., Hanel, A., et al. (2006) · Blood · doi:10.1182/blood-2006-04-016725 · Cited by 467
Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0046 · Cited by 454
Self-citationLiu, H., Ruskon-Fourmestraux, A., Lavergne-Slove, A., Ye, H., Molina, T., Bouhnik, Y., Hamoudi, R. A., Diss, T. C., Dogan, A., Megraud, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03571-6 · Cited by 446
Rummel, M. J., Al-Batran, S. E., Kim, S.-Z., Welslau, M., Hecker, R., Kofahl-Krause, D., Josten, K.-M., Dürk, H., Rost, A., Neise, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.100 · Cited by 441
Velasquez, W. S., McLaughlin, P., Tucker, S., Hagemeister, F. B., Swan, F., Rodriguez, M. A., Romaguera, J., Rubenstein, E., & Cabanillas, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1169 · Cited by 430
Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma
Cerroni, L., Zöchling, N., Pütz, B., & Kerl, H. (1997) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1997.tb01318.x · Cited by 415
Immunopathogenesis and therapy of cutaneous T cell lymphoma
Kim, E. J., Hess, S., Richardson, S. K., Newton, S., Showe, L. C., Benoit, B. M., Ubriani, R., Vittorio, C. C., Junkins-Hopkins, J. M., Wysocka, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24826 · Cited by 413
Kewalramani, T., Zelenetz, A. D., Nimer, S. D., Portlock, C., Straus, D., Noy, A., O'Connor, O., Filippa, D. A., Teruya-Feldstein, J., Gencarelli, A., et al. (2004) · Blood · doi:10.1182/blood-2003-11-3911 · Cited by 406
Self-citationByrd, J. C. (2005) · Blood · doi:10.1182/blood-2004-03-0796 · Cited by 404
Self-citationFlinn, I. W., Neuberg, D. S., Grever, M. R., Dewald, G. W., Bennett, J. M., Paietta, E. M., Hussein, M. A., Appelbaum, F. R., Larson, R. A., Moore, D. F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0762 · Cited by 402
Lozanski, G., Heerema, N. A., Flinn, I. W., Smith, L., Harbison, J., Webb, J., Moran, M., Lucas, M., Lin, T., Hackbarth, M. L., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3729 · Cited by 398
Self-citationLeporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., Rapp, M., Jaubert, J., Autrand, C., Diviné, M., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2319 · Cited by 391
Lundin, J., Hagberg, H., Repp, R., Cavallin-Ståhl, E., Fredén, S., Juliusson, G., Rosenblad, E., Tjønnfjord, G., Wiklund, T., & Österborg, A. (2003) · Blood · doi:10.1182/blood-2002-09-2802 · Cited by 390
Howard, O. M., Gribben, J. G., Neuberg, D. S., Grossbard, M. L., Poor, C., Janicek, M. J., & Shipp, M. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1288 · Cited by 372
Czuczman, M. S., Weaver, R., Alkuzweny, B., Berlfein, J., & Grillo-López, A. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.020 · Cited by 366
Self-citationSavage, K. J., Chhanabhai, M., Gascoyne, R. D., & Connors, J. M. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh392 · Cited by 363
Schulz, H., Bohlius, J. F., Trelle, S., Skoetz, N., Reiser, M., Kober, T., Schwarzer, G., Herold, M., Dreyling, M., Hallek, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk152 · Cited by 362
Foss, F. M., Zinzani, P. L., Vose, J. M., Gascoyne, R. D., Rosen, S. T., & Tobinai, K. (2011) · Blood · doi:10.1182/blood-2010-05-231548 · Cited by 353
Self-citationGrever, M. R., Lucas, D. M., Dewald, G. W., Neuberg, D. S., Reed, J. C., Kitada, S., Flinn, I. W., Tallman, M. S., Appelbaum, F. R., Larson, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3089 · Cited by 353
Self-citationHainsworth, J. D., Litchy, S., Barton, J. H., Houston, G. A., Hermann, R. C., Bradof, J. E., & Greco, F. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.027 · Cited by 351
Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic Leukemia
O’Brien, S. M., Kantarjian, H. M., Cortes, J., Beran, M., Koller, C. A., Giles, F. J., Lerner, S., & Keating, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1414 · Cited by 347
Mourad, N., Mounier, N., Brière, J., Raffoux, E., Delmer, A., Feller, A., Meijer, C. J. L. M., Emile, J.-F., Bouabdallah, R., Bosly, A., et al. (2008) · Blood · doi:10.1182/blood-2007-08-105759 · Cited by 346
Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D. M., von Schulthess, G., & Goerres, G. W. (2004) · Radiology · doi:10.1148/radiol.2323030985 · Cited by 344
Hainsworth, J. D., Litchy, S., Shaffer, D. W., Lackey, V. L., Grimaldi, M., & Greco, F. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.191 · Cited by 330
Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A. P., Repp, R., Schetelig, J., Seipelt, G., & Österborg, A. (2004) · Blood · doi:10.1182/blood-2003-10-3389 · Cited by 327
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
Wündisch, T., Thiede, C., Morgner, A., Dempfle, A., Günther, A., Liu, H., Ye, H., Du, M.-Q., Kim, T. D., Bayerdörffer, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3903 · Cited by 317
The role of FDG-PET scans in patients with lymphoma
Seam, P., Juweid, M. E., & Cheson, B. D. (2007) · Blood · doi:10.1182/blood-2007-06-097238 · Cited by 304
Moskowitz, C. H., Bertino, J. R., Glassman, J. R., Hedrick, E. E., Hunte, S., Coady-Lyons, N., Agus, D. B., Goy, A., Jurcic, J., Noy, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3776 · Cited by 302
Self-citationFriedberg, J. W., Cohen, P., Chen, L., Robinson, K. S., Forero-Torres, A., La Casce, A. S., Fayad, L. E., Bessudo, A., Camacho, E. S., Williams, M. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5070 · Cited by 296
Self-citationUtility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma
Hehn, S. T., Grogan, T. M., & Miller, T. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.104 · Cited by 292
Zinzani, P. L., Musuraca, G., Tani, M., Stefoni, V., Marchi, E., Fina, M., Pellegrini, C., Alinari, L., Derenzini, E., de Vivo, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4207 · Cited by 280
Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., & Fisher, R. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8198 · Cited by 280
Self-citationVergier, B., Muret, A. D., Beylot-Barry, M., Vaillant, L., Ekouévi, D. K., Chêne, G., Carlotti, A., Franck, N., Dechelotte, P., Souteyrand, P., et al. (2000) · PubMed · doi:10.1182/blood.v95.7.2212 · Cited by 263
Immunoproliferative small intestinal disease associated with Campylobacter jejuni
Lecuit, M. (2009) · Hematology Meeting Reports · doi:10.4081/hmr.v1i5.265 · Cited by 261
Miller, T., Grogan, T., Dahlberg, S., Spier, C., Braziel, R., Banks, P., Foucar, K., Kjeldsberg, C., Levy, N., & Nathwani, B. (1994) · Blood · doi:10.1182/blood.v83.6.1460.1460 · Cited by 256
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
Thomas, D. A., O'Brien, S., Cortes, J., Giles, F. J., Faderl, S., Verstovsek, S., Ferrajoli, A., Koller, C., Beran, M., Pierce, S., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4428 · Cited by 255
Döhner, H., Stilgenbauer, S., Döhner, K., Bentz, M., & Lichter, P. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050350 · Cited by 249
Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial
Steinbach, G., Ford, R., Glober, G., Sample, D., Hagemeister, F. B., Lynch, P. M., McLaughlin, P. W., Rodriguez, M. A., Romaguera, J. E., Sarris, A. H., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00003 · Cited by 242
Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.-C., Haioun, C., Delfau-Larue, M.-H., & Gaulard, P. (2006) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200604000-00009 · Cited by 236
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin
Roggero, E., Zucca, E., Mainetti, C., Bertoni, F., Valsangiacomo, C., Pedrinis, E., Borisch, B., Piffaretti, J.-C., Cavalli, F., & Isaacson, P. G. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80233-6 · Cited by 234
Sorror, M. L., Maris, M. B., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Hegenbart, U., Agura, E., Chauncey, T. R., Leis, J., Pulsipher, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.569 · Cited by 230
Stilgenbauer, S., & Döhner, H. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208083470619 · Cited by 216
Diagnosis and Subclassification of Primary and Recurrent Lymphoma
Meda, B. A., Buss, D. H., Woodruff, R. D., Cappellari, J. O., Rainer, R. O., Powell, B. L., & R.Geisinger, K. (2000) · American Journal of Clinical Pathology · doi:10.1309/0q7f-qtgm-6dpd-tlgy · Cited by 216
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
Wollina, U., Dummer, R., Brockmeyer, N. H., Konrad, H., Busch, J. ‐., Kaatz, M., Knopf, B., Koch, H., & Hauschild, A. (2003) · Cancer · doi:10.1002/cncr.11593 · Cited by 214
Isasi, C. R., Lu, P., & Blaufox, M. D. (2005) · Cancer · doi:10.1002/cncr.21253 · Cited by 208
Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci–Eradicating Antibiotic Therapy
Ferreri, A. J. M., Ponzoni, M., Guidoboni, M., De Conciliis, C., Resti, A. G., Mazzi, B., Lettini, A. A., Demeter, J., Dell'Oro, S., Doglioni, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.083 · Cited by 205
Dong, H. Y., Harris, N. L., Preffer, F. I., & Pitman, M. B. (2001) · Modern Pathology · doi:10.1038/modpathol.3880336 · Cited by 203
Self-citationKari, L., Loboda, A., Nebozhyn, M., Rook, A. H., Vonderheid, E. C., Nichols, C., Virok, D., Chang, C., Horng, W.-H., Johnston, J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021726 · Cited by 199
Primary Cutaneous Marginal Zone B-Cell Lymphoma: Clinical and Therapeutic Features in 50 Cases
Hoefnagel, J. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.9.1139 · Cited by 186
Optimizing bexarotene therapy for cutaneous T-cell lymphoma
Talpur, R., Ward, S., Apisarnthanarax, N., Breuer-McHam, J., & Duvic, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.124607 · Cited by 185
Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Gaynor, E. R., Rivkin, S. E., & Fisher, R. I. (2003) · Blood · doi:10.1182/blood-2003-01-0287 · Cited by 174
Self-citationKim, Y. H., Chow, S., Varghese, A., & Hoppe, R. T. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.1.26 · Cited by 172
Self-citationAIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy
Cheung, M. C., Pantanowitz, L., & Dezube, B. J. (2005) · The Oncologist · doi:10.1634/theoncologist.10-6-412 · Cited by 172
Kaufmann, H., Raderer, M., Wöhrer, S., Püspök, A., Bankier, A., Zielinski, C., Chott, A., & Drach, J. (2004) · Blood · doi:10.1182/blood-2004-03-1091 · Cited by 164
Heald, P., Mehlmauer, M., Martin, A. G., Crowley, C. A., Yocum, R. C., & Reich, S. D. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01475-0 · Cited by 162
Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma: Phase II study of 32 patients
Marchi, E., Alinari, L., Tani, M., Stefoni, V., Pimpinelli, N., Berti, E., Pagano, L., Bernengo, M. G., Zaja, F., Rupoli, S., et al. (2005) · Cancer · doi:10.1002/cncr.21449 · Cited by 161
Current Treatment Approaches for Mantle-Cell Lymphoma
Witzig, T. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.55.017 · Cited by 153
Querfeld, C. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.3.305 · Cited by 150
Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients
Zackheim, H. S., Kashani–Sabet, M., & McMillan, A. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01591-3 · Cited by 149
Lamanna, N., Kalaycio, M. E., Maslak, P. G., Jurcic, J. G., Heaney, M. L., Brentjens, R. J., Zelenetz, A. D., Horgan, D., Gencarelli, A. N., Panageas, K. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3836 · Cited by 149
Self-citationGrogg, K. L., Attygalle, A. D., Macon, W. R., Remstein, E. D., Kurtin, P. J., & Doǧan, A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800625 · Cited by 147
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Ahmad, A. S., Govil, Y. K., & Frank, B. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07424.x · Cited by 145
Interferon in the Treatment of Cutaneous T-cell Lymphoma
Olsen, E. A., & Bunn, P. A. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30060-1 · Cited by 144
Zinzani, P. L., Pulsoni, A., Perrotti, A. P., Soverini, S., Zaja, F. F., Renzo, A. D., Storti, S., Lauta, V. M., Guardigni, L., Gentilini, P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.170 · Cited by 143
The treatment of cutaneous T-cell lymphoma with photopheresis
Zic, J. A. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01646.x · Cited by 142
Zeppa, P., Marino, G., Troncone, G., Fulciniti, F., Renzo, A. D., Picardi, M., Benincasa, G., Rotoli, B., Vetrani, A., & Palombini, L. (2003) · Cancer · doi:10.1002/cncr.11903 · Cited by 136
Rodríguez‐Vigil, B., León, N. G., Pinilla, I., Hernández‐Maraver, D., Coya, J., Curto, L. M. M., & Madero, R. (2006) · PubMed · Cited by 133
Hermine, O., Allard, I., Lévy, V., Arnulf, B., Gessain, A., & Bazarbachi, A. A. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200195 · Cited by 132
Thurber, S. E., Zhang, B. M., Kim, Y. H., Schrijver, I., Zehnder, J. L., & Köhler, S. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.004 · Cited by 130
Self-citationCrump, M., Baetz, T. D., Couban, S., Belch, A. R., Marcellus, D. C., Howson‐Jan, K., Imrie, K., Myers, R. E., Adams, G., Ding, K., et al. (2004) · Cancer · doi:10.1002/cncr.20587 · Cited by 126
Peterson, B. A., Petroni, G. R., Frizzera, G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.128 · Cited by 125
Shenkier, T. N., Voss, N., Fairey, R. N., Gascoyne, R. D., Hoskins, P. J., Klasa, R. J., Klimo, P., O’Reilly, S. E., Sutcliffe, S. B. J., & Connors, J. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.197 · Cited by 124
Mycosis fungoides: radiation therapy
Hoppe, R. T. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01647.x · Cited by 123
Self-citationSuchin, K. R., Cucchiara, A. J., Gottleib, S. L., Wolfe, J. T., DeNardo, B. J., Macey, W. H., Bromley, P. G., Vittorio, C. C., & Rook, A. H. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.8.1054 · Cited by 123
Foss, F. M., Demierre, M., & DiVenuti, G. (2005) · Blood · doi:10.1182/blood-2004-11-4570 · Cited by 117
Sandherr, M., Einsele, H., Hebart, H. F., Kahl, C., Kern, W. V., Kiehl, M. G., Massenkeil, G., Penack, O., Schiel, X., Schüttrumpf, S., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj132 · Cited by 115
Applications of Flow Cytometry and Immunohistochemistry to Diagnostic Hematopathology
Dunphy, C. H. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1004-aofcai · Cited by 114
Lee, E. J., Petroni, G. R., Schiffer, C. A., Freter, C. E., Johnson, J. L., Barcos, M. P., Frizzera, G., Bloomfield, C. D., & Peterson, B. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4014 · Cited by 104
Fisher, R. I., Miller, T. P., & O’Connor, O. A. (2004) · Hematology · doi:10.1182/asheducation-2004.1.221 · Cited by 102
Fine needle aspiration cytology in the investigation on non-Hodgkin's lymphoma.
Jeffers, M. D., Milton, J., Herriot, R., & McKean, M. E. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.3.189 · Cited by 100
Straus, D. J., Duvic, M. A., Kuzel, T. M., Horwitz, S. M., Demierre, M., Myskowski, P. L., & Steckel, S. (2007) · Cancer · doi:10.1002/cncr.22596 · Cited by 97
Self-citationPathobiology of Peripheral T-cell Lymphomas
Jaffe, E. S. (2006) · Hematology · doi:10.1182/asheducation-2006.1.317 · Cited by 96
O'Brien, S. M., Keating, M. J., & Mocarski, E. S. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.n.049 · Cited by 91
Treatment of cutaneous T-cell lymphoma with retinoids
Zhang, C., & Duvic, M. A. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2006.00083.x · Cited by 89
Blayney, D. W., LeBlanc, M. L., Grogan, T. M., Gaynor, E. R., Chapman, R., Spiridonidis, C. H., Taylor, S. A., Bearman, S. I., Miller, T. P., & Fisher, R. I. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.137 · Cited by 76
Bazarbachi, A. A., & Hermine, O. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199600001-00028 · Cited by 75
Cyclophosphamide/Fludarabine (CF) is Active in the Treatment of Mantle Cell Lymphoma
Cohen, B. J., Moskowitz, C., Straus, D., Noy, A., Hedrick, E. E., & Zelenetz, A. D. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097721 · Cited by 75
Self-citationWhite, J. D., Wharfe, G., Stewart, D. M., Maher, V. E., Eicher, D. M., Herring, B., Derby, M., Jackson-Booth, P.-G., Marshall, M. A., Lucy, D., et al. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057927 · Cited by 74
Treatment of patch-stage mycosis fungoides with topical corticosteroids
Zackheim, H. S. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01639.x · Cited by 73
The Diagnosis, Staging, and Treatment Options for Mycosis Fungoides
Keehn, C. A., Belongie, I. P., Shistik, G., Fenske, N. A., & Glass, L. F. (2007) · Cancer Control · doi:10.1177/107327480701400203 · Cited by 68
Coleman, M., Martin, P., Ruan, J., Furman, R. R., Niesvizky, R., Elstrom, R., George, P., Kaufman, T., & Leonard, J. P. (2008) · Cancer · doi:10.1002/cncr.23422 · Cited by 67
Mey, U., Orlopp, K. S., Flieger, D., Strehl, J., Ho, A. D., Hensel, M., Bopp, C., Gorschlüter, M., Wilhelm, M., Birkmann, J., et al. (2006) · Cancer Investigation · doi:10.1080/07357900600814490 · Cited by 59
Querfeld, C., Rosen, S. T., Guitart, J., RADEMAKER, A. W., Fung, B. B., Posten, W., & Kuzel, T. M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.11.058 · Cited by 53
Psoralen Plus Long-Wave UV-A (PUVA) and Bexarotene Therapy
McGinnis, K. S., Shapiro, M., Vittorio, C. C., Rook, A. H., & Junkins‐Hopkins, J. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.6.771 · Cited by 52
Marginal zone-related neoplasms of splenic and nodal origin.
Arcaini, L., Paulli, M., Boveri, E., Magrini, U., & Lazzarino, M. (2003) · PubMed · Cited by 48
Arima, N., & Tsudo, M. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04170.x · Cited by 36
Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies
Park, S. I., & Press, O. W. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282efb17c · Cited by 36
Self-citationHagenbeek, A., Bischof-Delaloye, A., Radford, J. A., Rohatiner, A. Z. S., Salles, G., Hoof, A. V., Pütz, B., Kunz, M., & Morschhauser, F. (2007) · Blood · doi:10.1182/blood.v110.11.643.643 · Cited by 35
Vose, J. M., & Šneller, V. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg704 · Cited by 32
Self-citationRituximab maintenance therapy: a step forward in follicular lymphoma
van Oers, M. H. J. (2007) · Haematologica · doi:10.3324/haematol.10894 · Cited by 31
Jankowitz, R. C., Foon, K. A., DeMonaco, N. A., Osborn, J. L., Wu, M.-C., Evans, T. L., Swerdlow, S. H., JOYCE, J. M., Land, S. R., & Jacobs, S. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8005 · Cited by 8
(2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20001015)89:8
Cited by
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Byrd, J. C., Brown, J. R., O'Brien, S., Barrientos, J. C., Kay, N. E., Reddy, N. M., Coutre, S., Tam, C. S., Mulligan, S. P., Jaeger, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400376 · Cited by 1,639
Self-citationRummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grünhagen, U., Losem, C., Kofahl-Krause, D., Heil, G., Welslau, M., Balser, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61763-2 · Cited by 1,510
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4223 · Cited by 680
Self-citationClark, R. A., Watanabe, R., Teague, J. E., Schlapbach, C., Tawa, M. C., Adams, N., Dorosario, A. A., Chaney, K. S., Cutler, C. S., LeBoeuf, N. R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003008 · Cited by 367
Mechanisms of action of lenalidomide in B-cell non-Hodgkin lymphoma
Gribben, J. G., Fowler, N., & Morschhauser, F. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5363 · Cited by 296
Metadata
- Authors
- Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Byrd, J. C., Czuczman, M. S., Fayad, L., Forero, A., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kim, Y. H., LaCasce, A. S., Mughal, T. I., Nademanee, A., Porcu, P., Press, O., Prosnitz, L., Reddy, N., Smith, M. R., Sokol, L., Swinnen, L., Vose, J. M., Wierda, W. G., Yahalom, J., & Yunus, F.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2010-03
- Volume
- 8
- Issue
- 3
- Pages
- 288-334
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2976680230
- Cited by
- 329
- References
- 168
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.